Financials in USD. Standardized financial statements.
A compact view of how AnaptysBio, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $234.60M | $91.28M | $17.16M | $10.29M | $63.17M | $75.00M | $8.00M | $5.00M | $10.00M | $16.68M |
| Revenue Growth? | +157.0% | +432.0% | +66.8% | -83.7% | -15.8% | +837.5% | +60.0% | -50.0% | -40.1% | 0.0% |
| Cost of Revenue? | $2.42M | $163.84M | $132.28M | $88.80M | $98.50M | $80.03M | $99.34M | $56.20M | $29.44M | $15.42M |
| Gross Profit? | $232.18M | -$72.56M | -$115.13M | -$78.51M | -$35.32M | -$5.03M | -$91.34M | -$51.20M | -$19.44M | $1.26M |
| Gross Margin? | +99.0% | -79.5% | -671.0% | -763.2% | -55.9% | -6.7% | -1141.7% | -1023.9% | -194.4% | +7.6% |
| Operating Expenses? | $184.28M | $42.39M | $49.28M | $36.64M | $21.49M | $18.85M | $16.09M | $15.53M | $9.34M | $4.29M |
| Operating Income? | $47.90M | -$114.95M | -$164.41M | -$115.15M | -$56.81M | -$23.88M | -$107.43M | -$66.72M | -$28.78M | -$3.02M |
| EBITDA? | $50.32M | -$92.74M | -$156.42M | -$105.26M | -$55.71M | -$19.37M | -$95.93M | -$59.88M | -$28.11M | -$3.57M |
| Income Before Tax | -$13.07M | -$145.23M | -$163.62M | -$128.70M | -$57.80M | -$19.93M | -$97.49M | -$61.85M | -$30.07M | -$4.26M |
| Income Tax Expense | $164,000 | $3,000 | -$4,000 | $24,000 | $0 | $0 | -$152,000 | -$192,000 | $0 | $0 |
| Net Income? | -$13.23M | -$145.23M | -$163.62M | -$128.72M | -$57.80M | -$19.93M | -$97.34M | -$61.66M | -$30.07M | -$4.26M |
| EPS? | $-0.46 | $-5.12 | $-6.08 | $-4.57 | $-2.11 | $-0.73 | $-3.60 | $-2.50 | $-1.52 | $-0.23 |
| Diluted EPS? | $-0.46 | $-5.12 | $-6.08 | $-4.57 | $-2.11 | $-0.73 | $-3.60 | $-2.50 | $-1.52 | $-0.23 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality